Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 3)
Anemia, Sickle Cell (Phase 2)
Arrhythmias, Cardiac (Phase 4)
Brain Concussion (Phase 1)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Cardiovascular Diseases (Phase 3)
Child Development (Phase 3)
Cholangitis, Sclerosing (Phase 1)
Cognitive Dysfunction (Early Phase 1)
Colitis (Phase 1)
Colorectal Neoplasms (Phase 2)
Coronary Artery Disease (Phase 4)
Cystic Fibrosis (Phase 2)
Depression (Phase 3)
Diabetes, Gestational (Phase 1)
Fatty Acids (Phase 3)
Fatty Liver (Phase 3)
Genetic Diseases, X-Linked (Phase 2)
Gingivitis (Phase 2)
Healthy Volunteers (Phase 1)
HIV Infections (Phase 3)
Hypertension, Pregnancy-Induced (Phase 1)
Hypertriglyceridemia (Phase 2)
Infant, Premature, Diseases (Phase 2)
Inflammation (Phase 3)
Insulin Resistance (Phase 1)
Liver Cirrhosis (Phase 3)
Lung Neoplasms (Phase 2/Phase 3)
Macula Lutea (Phase 4)
Macular Degeneration (Phase 1)
Metabolic Syndrome (Phase 3)
Muscular Dystrophy, Duchenne (Phase 2)
Neonatology (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 3)
Obesity (Phase 3)
Oxidative Stress (Phase 2/Phase 3)
Parkinson Disease (Phase 1)
Periodontitis (Phase 2)
Pre-Eclampsia (Phase 1)
Pregnancy (Phase 3)
Premature Birth (Phase 3)
Psychotic Disorders (Phase 2)
Retinitis Pigmentosa (Phase 2)
Schizophrenia (Phase 2/Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue